Clarus Iv-a, L.p. - Net Worth and Insider Trading
Clarus Iv-a, L.p. Net Worth
The estimated net worth of Clarus Iv-a, L.p. is at least $315,313 dollars as of 2024-05-01. Clarus Iv-a, L.p. is the 10% Owner of Galera Therapeutics Inc and owns about 1,678,984 shares of Galera Therapeutics Inc (GRTX) stock worth over $315,313. Details can be seen in Clarus Iv-a, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Clarus Iv-a, L.p. has not made any transactions after 2019-11-12 and currently still holds the listed stock(s).
Transaction Summary of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Clarus Iv-a, L.p. owns 2 companies in total, including Galera Therapeutics Inc (GRTX) , and Talaris Therapeutics Inc (TALS) .
Click here to see the complete history of Clarus Iv-a, L.p.’s form 4 insider trades.
Insider Ownership Summary of Clarus Iv-a, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 10 percent owner |
| TALS | Talaris Therapeutics Inc | 2021-05-06 | 10 percent owner |
Clarus Iv-a, L.p. Latest Holdings Summary
Clarus Iv-a, L.p. currently owns a total of 1 stock. Clarus Iv-a, L.p. owns 1,678,984 shares of Galera Therapeutics Inc (GRTX) as of November 12, 2019, with a value of $315,313.
Latest Holdings of Clarus Iv-a, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GRTX | Galera Therapeutics Inc | 2019-11-12 | 1,678,984 | 0.19 | 315,313 |
Holding Weightings of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Clarus Iv-a, L.p. has made a total of 1 transactions in Galera Therapeutics Inc (GRTX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galera Therapeutics Inc is the acquisition of 250,000 shares on November 12, 2019, which cost Clarus Iv-a, L.p. around $3 Million.
Insider Trading History of Clarus Iv-a, L.p.
- 1
Clarus Iv-a, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Clarus Iv-a, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Clarus Iv-a, L.p. is 6.05%. GuruFocus also compares Clarus Iv-a, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Clarus Iv-a, L.p. within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Clarus Iv-a, L.p.'s insider trading performs compared to the benchmark.
Performance of Clarus Iv-a, L.p.
Average Return
-16.97%
Outperforming Transactions
0%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -30.04 | 6.05 | -10.73 | -16.97 | -63.65 | -49.11 |
| Relative Return to S&P 500(%) | -32.52 | -3.25 | -3.56 | -31.33 | -86.68 | -58.01 |
Clarus Iv-a, L.p. Ownership Network
Ownership Network List of Clarus Iv-a, L.p.
Ownership Network Relation of Clarus Iv-a, L.p.
Clarus Iv-a, L.p. Owned Company Details
What does Galera Therapeutics Inc do?
Who are the key executives at Galera Therapeutics Inc?
Clarus Iv-a, L.p. is the 10 percent owner of Galera Therapeutics Inc. Other key executives at Galera Therapeutics Inc include Chief Commercial Officer Mark Bachleda , Chief Financial Officer Chris Degnan , and director & President and CEO Mel Sorensen .
Galera Therapeutics Inc (GRTX) Insider Trades Summary
Over the past 18 months, Clarus Iv-a, L.p. made no insider transaction in Galera Therapeutics Inc (GRTX). Other recent insider transactions involving Galera Therapeutics Inc (GRTX) include a net purchase of 932,402 shares made by , a net purchase of 100,000 shares made by Mel Sorensen , and a net purchase of 11,000 shares made by Mark Bachleda .
In summary, during the past 3 months, insiders sold 0 shares of Galera Therapeutics Inc (GRTX) in total and bought 932,402 shares, with a net purchase of 932,402 shares. During the past 18 months, 0 shares of Galera Therapeutics Inc (GRTX) were sold and 1,053,402 shares were bought by its insiders, resulting in a net purchase of 1,053,402 shares.
Galera Therapeutics Inc (GRTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Galera Therapeutics Inc Insider Transactions
Clarus Iv-a, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Clarus Iv-a, L.p.. You might contact Clarus Iv-a, L.p. via mailing address: 101 Main Street, Suite 1210, Cambridge Ma 02142.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
